Rheumatoid Arthritis

A 52-week randomised, partly double-blind trial in RA (n=40, on background sulfasalazine or hydroxychloroquine) using a purified pentacyclic-chemotype U. tomentosa extract reported a modest reduction in tender joints versus placebo (53% vs 24%) ^{4Reference 4Mur et al. · 2002RCTRandomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis — randomised controlled trialView study →}, consistent with the herb’s well-mapped NF-κB → TNF-α/IL-1β/PGE2 inhibition ^{5,6,7Reference 5Sandoval-Chacón et al. · 1998In vitroAntiinflammatory actions of cat’s claw: the role of NF-κB — in vitro/animalView study →Reference 6Allen-Hall et al. · 2010In vitroUncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB — in vitroView study →Reference 7Sandoval et al. · 2002In vitroAnti-inflammatory and antioxidant activities of cat’s claw are independent of their alkaloid content — in vitroView study →}.

The trial is small, single-site and unreplicated, and used a specific purified extract rather than whole bark.

A 50% aqueous-ethanolic root extract gave 71% protection against complete-Freund’s-adjuvant arthritis in rats (approaching dexamethasone) alongside dose-dependent antinociception ^{1Reference 1Amresh et al. · 2007AnimalAntinociceptive and antiarthritic activity of Cissampelos pareira roots — animal model (mouse/rat)View study →}. The result comes from a single unreplicated arthritis model at high doses, and there are no human data.

Black ant has no RA-specific study. The closest support is anti-inflammatory and analgesic data, much of it on the related ant Polyrhachis lamellidens: an ethanol extract inhibited xylene-induced ear oedema and acetic-acid vascular permeability in mice, and raised the hot-plate threshold while suppressing acetic-acid writhing at 1.5–3.0 g crude drug/kg ^{2Reference 2Kou et al. · 2005AnimalAnalgesic and anti-inflammatory activities of total extract and individual fractions of Chinese medicinal ants Polyrhachis lamellidens — mouse in vivoView study →}; the active fraction AFPR also lowered IL-1β, IL-6 and TNF-α in hyperuricaemic rats ^{3Reference 3Su et al. · 2018AnimalHypouricemic and nephroprotective effects of an active fraction from Polyrhachis vicina Roger on potassium-oxonate-induced hyperuricemia in rats — animal in vivoView study →}.

The signal is a general anti-inflammatory and analgesic one, consistent with traditional use for rheumatic pain but not tested in rheumatoid arthritis. It comes from a different species and, for the oedema/analgesia work, a whole-animal model rather than the marketed P. vicina/dives tonic.

In a collagen-induced arthritis model a related Corydalis species (C. decumbens) and its alkaloid tetrahydropalmatrubin reduced macrophage inflammation via the transcription factor Fosl2 ^{8Reference 8Gao P et al et al. · 2025In vitroCorydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2 — rat, in vivo, in vitroView study →}, and in cultured LPS-stimulated macrophages dehydrocorydaline carried most of the rhizome’s anti-inflammatory, cytokine-lowering activity ^{9,10Reference 9Kong X et al et al. · 2020In vitroDehydrocorydaline Accounts the Majority of Anti-Inflammatory Property of Corydalis Rhizoma in Cultured Macrophage — in vitroView study →Reference 10Xia GY et al et al. · 2022In vitroXia GY et al. (2022). 13,13a-seco-protoberberines from the tubers of Corydalis yanhusuo and their anti-inflammatory activity — in vitro. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/34839130/View study →}.

No human RA trial exists, the key arthritis-model data are from a different Corydalis species, and whole-tuber dosing has not been mapped to these effects. The case for RA rests on this mechanism and on corydalis’s analgesic activity.

Nigella has no RA-specific trial. Human biomarker meta-analyses show nigella lowers hs-CRP, TNF-α and MDA while raising antioxidant capacity ^{11,12Reference 11Montazeri RS et al. · 2021Meta-analysisThe effect of Nigella sativa on biomarkers of inflammation and oxidative stress — systematic review and meta-analysis of randomized controlled trialsView study →Reference 12Tavakoly R et al. · 2019Meta-analysisThe effect of Nigella sativa L. supplementation on serum C-reactive protein — systematic review and meta-analysis of randomized clinical trialsView study →}, driven by thymoquinone suppression of NF-κB and Nrf2 induction ^{13Reference 13Talebi M et al. · 2021ReviewBiological and therapeutic activities of thymoquinone — focus on the Nrf2 signaling pathway — reviewView study →}.

Cannabis is used in RA on the same anti-inflammatory rationale as in osteoarthritis, with no RA-specific trial. The use is symptomatic (pain, sleep) rather than disease-modifying.

Couchgrass is a traditional remedy for ‘rheumatism’ and rheumatic complaints, with no RA-specific or immunomodulatory evidence.

Licorice’s anti-inflammatory mechanism (NLRP3/NF-κB inhibition) is preclinical, and there is no RA clinical trial. Prolonged licorice use carries a blood-pressure and potassium caution.

Magnolia’s anti-inflammatory action (NF-κB↓, COX-2↓) is entirely preclinical, and none of it was tested in a joint or RA model.

Willow’s only direct RA data come from the parallel rheumatoid-arthritis arm of the Biegert trial, which was null and severely underpowered (n=26) ^{14Reference 14Biegert et al. · 2004RCTEfficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials — RCTView study →}.

The general anti-inflammatory mechanism (COX-2, cytokine and leukotriene suppression) is well mapped in rat and cell models ^{15,16Reference 15Khayyal et al. · 2005AnimalMechanisms involved in the anti-inflammatory effect of a standardized willow bark extract — animal model (rat)View study →Reference 16Nahrstedt et al. · 2007ReviewWillow bark extract: the contribution of polyphenols to the overall effect — reviewView study →} but has never been tested against an RA endpoint in humans.